Baricitinib is an Orally Active JAK1/2 Inhibitor for Inflammation Research
Janus kinase (JAK) is a family of intracellular, non-receptor tyrosine kinases that transduce cytokine-mediated signals via the JAK-STAT pathway. Importantly, JAK1 and JAK2 are one of the human tyrosine kinase…